Nexgel Financials

NXGL Stock  USD 2.84  0.04  1.39%   
Nexgel Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Nexgel's Non Currrent Assets Other are quite stable compared to the past year. Net Receivables is expected to rise to about 764.3 K this year, although the value of Total Stockholder Equity will most likely fall to about 3.7 M. Key indicators impacting Nexgel's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.650.69
Notably Down
Very volatile
Current Ratio1.91.78
Notably Up
Slightly volatile
The essential information of the day-to-day investment outlook for Nexgel includes many different criteria found on its balance sheet. An individual investor should monitor Nexgel's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Nexgel.

Net Income

(2.98 Million)

  

Nexgel Stock Summary

Nexgel competes with GlucoTrack, Predictive Oncology, Pro Dex, JIN MEDICAL, and Nyxoah. NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania. Nexgel operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS65344E1073
CUSIP65344E107
LocationPennsylvania; U.S.A
Business Address2150 Cabot Boulevard
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitenexgel.com
Phone215 702 8550
CurrencyUSD - US Dollar

Nexgel Key Financial Ratios

Nexgel Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets2.3M17.0M10.4M10.0M11.4M6.1M
Other Current Liab213K380K113K738K848.7K891.1K
Accounts Payable658K254K265K1.2M1.4M1.5M
Net Receivables73K209K222K633K728.0K764.3K
Inventory233K291K502K1.3M1.5M1.6M
Total Liab2.2M4.9M2.7M4.8M5.5M5.8M
Total Current Assets363K13.9M7.5M5.1M5.8M3.9M
Common Stock281K57K99K6K5.4K5.1K
Net Tangible Assets380K(287K)11.7M7.3M8.4M8.8M
Net Invested Capital543K14.4M7.9M5.5M6.4M5.3M
Net Working Capital(969K)11.0M6.6M2.5M2.9M3.5M
Net Debt1.2M(9.1M)982K98K88.2K92.6K
Retained Earnings(2.5M)(6.8M)(11.6M)(14.7M)(13.2M)(12.6M)
Cash32K13.4M1.1M2.7M3.1M3.8M
Short Term Debt423K2.3M429K558K641.7K851.6K

Nexgel Key Income Statement Accounts

202020212022202320242025 (projected)
Total Revenue674K1.6M2.0M4.1M4.7M4.9M
Gross Profit(291K)9K256K619K711.9K747.4K
Operating Income(2.3M)(2.6M)(3.3M)(3.5M)(3.1M)(3.3M)
Ebit(2.3M)(2.3M)(3.4M)(3.2M)(2.9M)(3.0M)
Ebitda(2.2M)(2.2M)(3.1M)(2.7M)(2.5M)(2.6M)
Cost Of Revenue965K1.5M1.8M3.5M4.0M4.2M
Income Before Tax(2.3M)(4.3M)(4.7M)(3.2M)(2.9M)(3.0M)
Net Income(2.3M)(6.3M)(6.1M)(3.2M)(2.8M)(3.0M)
Income Tax Expense18K2.0M1.4M(31K)(35.7K)(33.9K)
Interest Expense10K2.0M1.3M15K17.3K16.4K
Net Interest Income(10K)(2.0M)(1.3M)(12K)(10.8K)(11.3K)

Nexgel Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(99K)(58K)(211K)(760K)(684K)(649.8K)
Change In Cash(229K)13.3M(12.2M)1.6M1.4M1.5M
Free Cash Flow(2.1M)(3.0M)(3.1M)(3.9M)(3.5M)(3.4M)
Depreciation50K113K301K443K509.5K266.2K
Other Non Cash Items2K2.0M1.4M(318K)(365.7K)(347.4K)
Net Income(2.3M)(4.3M)(4.7M)(3.2M)(2.8M)(3.0M)
Change To Netincome3K234K104K552K634.8K666.5K
Investments(312K)(269K)(5.6M)5.2M6.0M6.3M
End Period Cash Flow32K13.4M1.1M2.7M3.1M3.2M

Nexgel Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nexgel's current stock value. Our valuation model uses many indicators to compare Nexgel value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nexgel competition to find correlations between indicators driving Nexgel's intrinsic value. More Info.
Nexgel Inc is rated below average in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . At this time, Nexgel's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Nexgel by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Nexgel Inc Systematic Risk

Nexgel's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nexgel volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Nexgel Inc correlated with the market. If Beta is less than 0 Nexgel generally moves in the opposite direction as compared to the market. If Nexgel Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nexgel Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nexgel is generally in the same direction as the market. If Beta > 1 Nexgel moves generally in the same direction as, but more than the movement of the benchmark.

Nexgel Thematic Clasifications

Nexgel Inc is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Medical EquipmentView
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Nexgel Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nexgel's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nexgel growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0852

At this time, Nexgel's Price Earnings To Growth Ratio is quite stable compared to the past year.

Nexgel March 19, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Nexgel help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nexgel Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nexgel Inc based on widely used predictive technical indicators. In general, we focus on analyzing Nexgel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nexgel's daily price indicators and compare them against related drivers.
When determining whether Nexgel Inc is a strong investment it is important to analyze Nexgel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexgel's future performance. For an informed investment choice regarding Nexgel Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.59)
Revenue Per Share
1.097
Quarterly Revenue Growth
1.408
Return On Assets
(0.24)
Return On Equity
(0.68)
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.